At the time of writing, Angiodynamic Inc [ANGO] stock is trading at $12.46, up 1.30%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ANGO shares have gain 37.22% over the last week, with a monthly amount glided 40.16%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Angiodynamic Inc [NASDAQ: ANGO] stock has seen the most recent analyst activity on April 05, 2024, when Oppenheimer upgraded its rating to a Outperform but kept the price target unchanged to $12 for it. Previously, H.C. Wainwright started tracking the stock with Buy rating on September 25, 2023, and set its price target to $19. On April 17, 2023, downgrade downgraded it’s rating to Outperform and revised its price target to $13 on the stock. Canaccord Genuity upgraded its rating to a Buy and increased its price target to $37 on October 15, 2021. Oppenheimer initiated its recommendation with a Perform. Raymond James upgraded its rating to Strong Buy for this stock on November 25, 2020, but kept the price target unchanged to $18. In a note dated April 08, 2020, KeyBanc Capital Markets downgraded an Sector Weight rating on this stock.
For the past year, the stock price of Angiodynamic Inc fluctuated between $5.26 and $13.13. Currently, Wall Street analysts expect the stock to reach $13 within the next 12 months. Angiodynamic Inc [NASDAQ: ANGO] shares were valued at $12.46 at the most recent close of the market. An investor can expect a potential return of 4.33% based on the average ANGO price forecast.
Analyzing the ANGO fundamentals
According to Angiodynamic Inc [NASDAQ:ANGO], the company’s sales were 286.50M for trailing twelve months, which represents an -7.88% plunge. Gross Profit Margin for this corporation currently stands at 0.51% with Operating Profit Margin at -0.12%, Pretax Profit Margin comes in at -0.83%, and Net Profit Margin reading is -0.78%. To continue investigating profitability, this company’s Return on Assets is posted at -0.77, Equity is -1.11 and Total Capital is -0.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.79 points at the first support level, and at 11.13 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.85, and for the 2nd resistance point, it is at 13.25.
Ratios To Look Out For
It is important to note that Angiodynamic Inc [NASDAQ:ANGO] has a current ratio of 1.98. As well, the Quick Ratio is 1.24, while the Cash Ratio is 0.61. Considering the valuation of this stock, the price to sales ratio is 1.76, the price to book ratio is 2.72.
Transactions by insiders
Recent insider trading involved Nighan Warren JR, SVP Quality and Regulatory, that happened on Oct 07 ’24 when 768.0 shares were purchased. SVP Quality and Regulatory, Nighan Warren JR completed a deal on Oct 10 ’24 to buy 100.0 shares. Meanwhile, EVP and CFO Trowbridge Stephen A bought 1700.0 shares on Oct 08 ’24.
